Go to content

Orion

Feb 8th 2012
  • Suomeksi
  • Text size
  •  Home 
  •  Orion 
  •  Products and services 
  • Research and development
  •  News and media 
  •  Investors 
  •  Sustainability 
  • Careers
  • Proprietary Product Development
  • Generic Development
  • Therapy areas of research
  • Achievements
  • R&D People
  • R&D collaboration partnerships
  • R&D Vocabulary
  • The Best R&D in the World
Home / Research and development

Therapy areas of research

Central Nervous System medicines

Oncology and Critical care

Inhaled medicinal products - the Easyhaler® platform

Generics

Animal Health

 

Actual

 

Orion receives European marketing authorisation for dexdor®

 
Orion Corporation, Orionintie 1A, 02200 Espoo, PO Box 65, FI-02101 Espoo, Finland
Phone +358 104261 © Copyright Orion Corporation. Company code, VAT 19992126,
  • Contacts
  • About this website
  • Disclaimer
  • Sitemap
  • Feedback form